RESEARCHTEVA.TAabout 2 months ago10.3Kviews

Teva: three launches inside eighteen months, limited competition on two

The leverage that justified the discount has come down four turns while the pipeline improved. Neither has been re-rated.

Sofia Lindqvist@sofia_lindqvist

Unlock the full report

The locked call and the disclosures stay visible. The research body unlocks with purchase or subscription.

Fact-checked claims stay on the record
Platform fee is shown as its own line at checkout (10%)
Call block and disclosures remain free to read

Sign in to unlock

Already subscribed? Log in

Discussion · 0

Sign in to join the discussion.

No comments yet.

This is research, not financial advice. Calls lock at publish and are graded by the market; they can be and often are wrong. Do your own research and consider your own circumstances before acting.